Cargando…

Venous thromboembolism incidence in the Ireland east hospital group: a retrospective 22-month observational study

OBJECTIVES: To determine the incidence of venous thromboembolism (VTE) and the incidence of hospital-acquired VTE (HA-VTE) arising within the population served by the Ireland East Hospital Group (IEHG). DESIGN: /home/user/Documents/Sathish Kumar G/RFO/June/21-06-2019/bmjopen_iss_9_7_20190621_1/ A re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kevane, Barry, Day, Mary, Bannon, Noirin, Lawler, Leo, Breslin, Tomas, Andrews, Claire, Johnson, Howard, Fitzpatrick, Michael, Murphy, Karen, Mason, Olivia, O’Neill, Annemarie, Donohue, Fionnuala, Ní Áinle, Fionnuala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596982/
https://www.ncbi.nlm.nih.gov/pubmed/31230035
http://dx.doi.org/10.1136/bmjopen-2019-030059
_version_ 1783430528860422144
author Kevane, Barry
Day, Mary
Bannon, Noirin
Lawler, Leo
Breslin, Tomas
Andrews, Claire
Johnson, Howard
Fitzpatrick, Michael
Murphy, Karen
Mason, Olivia
O’Neill, Annemarie
Donohue, Fionnuala
Ní Áinle, Fionnuala
author_facet Kevane, Barry
Day, Mary
Bannon, Noirin
Lawler, Leo
Breslin, Tomas
Andrews, Claire
Johnson, Howard
Fitzpatrick, Michael
Murphy, Karen
Mason, Olivia
O’Neill, Annemarie
Donohue, Fionnuala
Ní Áinle, Fionnuala
author_sort Kevane, Barry
collection PubMed
description OBJECTIVES: To determine the incidence of venous thromboembolism (VTE) and the incidence of hospital-acquired VTE (HA-VTE) arising within the population served by the Ireland East Hospital Group (IEHG). DESIGN: /home/user/Documents/Sathish Kumar G/RFO/June/21-06-2019/bmjopen_iss_9_7_20190621_1/ A retrospective observational study was conducted using hospital discharge data obtained from the hospital inpatient enquiry data reporting system. In this system, VTE events recorded as ‘primary diagnosis’ represented the reason for initial hospital admission, whereas VTE recorded as a ‘secondary diagnosis’ occurred following admission and were therefore used as an approximation of HA-VTE. These data were used to estimate the overall incidence of VTE and the proportion of these events which were hospital-acquired. SETTING: The IEHG is the largest hospital group in the Irish healthcare system and serves a population of over 1 million individuals. PARTICIPANTS: Data were generated from records pertaining to the 2727 patient admission episodes where a diagnosis of VTE was made during the 22-month study period. RESULTS: During the study period, 2727 VTE events were recorded within the IEHG (which serves a population of 1 036 279) corresponding to an incidence of 1.44 (95% CI 1.36 to 1.51) per 1000 per annum. 1273 (47%) of VTE events were recorded as secondary VTE. The incidence of VTE was highest among individuals over 85 years of age (16.03 per 1000;95% CI 12.81 to 19.26) and was more common following emergency hospital admission. CONCLUSION: These data suggest that HA-VTE accounts for at least 47% of all VTE events arising within a hospital group serving a population of over 1 million individuals within the Ireland. Given that HA-VTE is a well-recognised source of (potentially preventable) hospital deaths, these findings provide a compelling argument for prioritising strategies directed at reducing the risk of VTE among hospital patients served by the IEHG and within the Ireland as a whole.
format Online
Article
Text
id pubmed-6596982
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-65969822019-07-18 Venous thromboembolism incidence in the Ireland east hospital group: a retrospective 22-month observational study Kevane, Barry Day, Mary Bannon, Noirin Lawler, Leo Breslin, Tomas Andrews, Claire Johnson, Howard Fitzpatrick, Michael Murphy, Karen Mason, Olivia O’Neill, Annemarie Donohue, Fionnuala Ní Áinle, Fionnuala BMJ Open Haematology (Incl Blood Transfusion) OBJECTIVES: To determine the incidence of venous thromboembolism (VTE) and the incidence of hospital-acquired VTE (HA-VTE) arising within the population served by the Ireland East Hospital Group (IEHG). DESIGN: /home/user/Documents/Sathish Kumar G/RFO/June/21-06-2019/bmjopen_iss_9_7_20190621_1/ A retrospective observational study was conducted using hospital discharge data obtained from the hospital inpatient enquiry data reporting system. In this system, VTE events recorded as ‘primary diagnosis’ represented the reason for initial hospital admission, whereas VTE recorded as a ‘secondary diagnosis’ occurred following admission and were therefore used as an approximation of HA-VTE. These data were used to estimate the overall incidence of VTE and the proportion of these events which were hospital-acquired. SETTING: The IEHG is the largest hospital group in the Irish healthcare system and serves a population of over 1 million individuals. PARTICIPANTS: Data were generated from records pertaining to the 2727 patient admission episodes where a diagnosis of VTE was made during the 22-month study period. RESULTS: During the study period, 2727 VTE events were recorded within the IEHG (which serves a population of 1 036 279) corresponding to an incidence of 1.44 (95% CI 1.36 to 1.51) per 1000 per annum. 1273 (47%) of VTE events were recorded as secondary VTE. The incidence of VTE was highest among individuals over 85 years of age (16.03 per 1000;95% CI 12.81 to 19.26) and was more common following emergency hospital admission. CONCLUSION: These data suggest that HA-VTE accounts for at least 47% of all VTE events arising within a hospital group serving a population of over 1 million individuals within the Ireland. Given that HA-VTE is a well-recognised source of (potentially preventable) hospital deaths, these findings provide a compelling argument for prioritising strategies directed at reducing the risk of VTE among hospital patients served by the IEHG and within the Ireland as a whole. BMJ Publishing Group 2019-06-21 /pmc/articles/PMC6596982/ /pubmed/31230035 http://dx.doi.org/10.1136/bmjopen-2019-030059 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Haematology (Incl Blood Transfusion)
Kevane, Barry
Day, Mary
Bannon, Noirin
Lawler, Leo
Breslin, Tomas
Andrews, Claire
Johnson, Howard
Fitzpatrick, Michael
Murphy, Karen
Mason, Olivia
O’Neill, Annemarie
Donohue, Fionnuala
Ní Áinle, Fionnuala
Venous thromboembolism incidence in the Ireland east hospital group: a retrospective 22-month observational study
title Venous thromboembolism incidence in the Ireland east hospital group: a retrospective 22-month observational study
title_full Venous thromboembolism incidence in the Ireland east hospital group: a retrospective 22-month observational study
title_fullStr Venous thromboembolism incidence in the Ireland east hospital group: a retrospective 22-month observational study
title_full_unstemmed Venous thromboembolism incidence in the Ireland east hospital group: a retrospective 22-month observational study
title_short Venous thromboembolism incidence in the Ireland east hospital group: a retrospective 22-month observational study
title_sort venous thromboembolism incidence in the ireland east hospital group: a retrospective 22-month observational study
topic Haematology (Incl Blood Transfusion)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596982/
https://www.ncbi.nlm.nih.gov/pubmed/31230035
http://dx.doi.org/10.1136/bmjopen-2019-030059
work_keys_str_mv AT kevanebarry venousthromboembolismincidenceintheirelandeasthospitalgrouparetrospective22monthobservationalstudy
AT daymary venousthromboembolismincidenceintheirelandeasthospitalgrouparetrospective22monthobservationalstudy
AT bannonnoirin venousthromboembolismincidenceintheirelandeasthospitalgrouparetrospective22monthobservationalstudy
AT lawlerleo venousthromboembolismincidenceintheirelandeasthospitalgrouparetrospective22monthobservationalstudy
AT breslintomas venousthromboembolismincidenceintheirelandeasthospitalgrouparetrospective22monthobservationalstudy
AT andrewsclaire venousthromboembolismincidenceintheirelandeasthospitalgrouparetrospective22monthobservationalstudy
AT johnsonhoward venousthromboembolismincidenceintheirelandeasthospitalgrouparetrospective22monthobservationalstudy
AT fitzpatrickmichael venousthromboembolismincidenceintheirelandeasthospitalgrouparetrospective22monthobservationalstudy
AT murphykaren venousthromboembolismincidenceintheirelandeasthospitalgrouparetrospective22monthobservationalstudy
AT masonolivia venousthromboembolismincidenceintheirelandeasthospitalgrouparetrospective22monthobservationalstudy
AT oneillannemarie venousthromboembolismincidenceintheirelandeasthospitalgrouparetrospective22monthobservationalstudy
AT donohuefionnuala venousthromboembolismincidenceintheirelandeasthospitalgrouparetrospective22monthobservationalstudy
AT niainlefionnuala venousthromboembolismincidenceintheirelandeasthospitalgrouparetrospective22monthobservationalstudy